Keay Nakae
Stock Analyst at Chardan Capital
(2.95)
# 1,271
Out of 4,880 analysts
234
Total ratings
28.82%
Success rate
3.62%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COYA Coya Therapeutics | Maintains: Buy | $14 | $5.81 | +141.04% | 19 | Jul 1, 2025 | |
| IBIO iBio, Inc. | Maintains: Buy | $5 | $0.73 | +589.66% | 5 | Jun 25, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $60 | $33.54 | +78.91% | 1 | Jun 23, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $50 | $9.18 | +444.66% | 12 | Jun 17, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $5.94 | +489.23% | 12 | Jun 13, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $65 → $75 | $29.38 | +155.28% | 17 | Jun 9, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 | $1.73 | +1,055.67% | 15 | May 15, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $2.88 | +594.44% | 10 | May 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $13.46 | +85.74% | 2 | May 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $16.60 | +261.45% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $10.62 | -43.50% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $325 | $326.52 | -0.47% | 13 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $2.37 | +743.88% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.63 | +268.10% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $3.27 | +52.91% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.47 | +1.21% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $2.07 | +93.70% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.93 | +760.40% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.19 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $11.03 | -45.60% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.45 | +4,325.76% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $7.10 | +674.65% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $6.19 | +61.55% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $13.32 | +556.91% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $0.92 | +1,315.97% | 3 | Feb 9, 2021 |
Coya Therapeutics
Jul 1, 2025
Maintains: Buy
Price Target: $14
Current: $5.81
Upside: +141.04%
iBio, Inc.
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.73
Upside: +589.66%
Monopar Therapeutics
Jun 23, 2025
Initiates: Buy
Price Target: $60
Current: $33.54
Upside: +78.91%
Dyne Therapeutics
Jun 17, 2025
Maintains: Buy
Price Target: $50
Current: $9.18
Upside: +444.66%
Silence Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $35
Current: $5.94
Upside: +489.23%
Avidity Biosciences
Jun 9, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $29.38
Upside: +155.28%
SAB Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $20
Current: $1.73
Upside: +1,055.67%
Orchestra BioMed Holdings
May 13, 2025
Maintains: Buy
Price Target: $20
Current: $2.88
Upside: +594.44%
Korro Bio
May 13, 2025
Maintains: Buy
Price Target: $25
Current: $13.46
Upside: +85.74%
Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $60
Current: $16.60
Upside: +261.45%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $10.62
Upside: -43.50%
May 2, 2025
Maintains: Buy
Price Target: $300 → $325
Current: $326.52
Upside: -0.47%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $2.37
Upside: +743.88%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.63
Upside: +268.10%
Mar 28, 2025
Maintains: Buy
Price Target: $5
Current: $3.27
Upside: +52.91%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.47
Upside: +1.21%
Mar 14, 2025
Maintains: Buy
Price Target: $4
Current: $2.07
Upside: +93.70%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.93
Upside: +760.40%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $11.03
Upside: -45.60%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.45
Upside: +4,325.76%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $7.10
Upside: +674.65%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $6.19
Upside: +61.55%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $13.32
Upside: +556.91%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $0.92
Upside: +1,315.97%